Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. How Do MMJ Restrictions Affect Patients and Doctors? Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

Veriheal

NOVEMBER 17, 2020

Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. Ohio became the 25th state to legalize medical cannabis back on June 8 of 2016. Medical cannabis is now available to residents in Ohio who meet one of 22 qualifying conditions laid out by House Bill 523.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Veriheal

APRIL 7, 2022

While cannabis’ potential to assist with MS has been known for some time now, it’s important to bolster previous findings with expansive research. As with many other conditions, there is a lack of research regarding the use of MMJ as an alternative treatment to relieve symptoms of MS. .

Patients 98

Patients Treatment Cannabinoids Pharmaceutical 98

CannaMD

NOVEMBER 8, 2021

In recognition of this information, a significant but still limited number of Parkinson’s patients have turned to cannabis as a complementary therapy to traditional pharmaceutical options. A survey of current […].

Patients 102

Patients Therapy Pharmaceutical Marijuana 102

Cannabis Law Report

SEPTEMBER 29, 2022

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. The Therapeutic Goods Administration (TGA) issued 73 infringement notices totalling $972,360 between the medicinal cannabis companies MGC Pharmaceuticals Ltd, Cannatrek Ltd and Little Green Pharma Ltd.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. In 2020, the law changed to allow patients with any medical condition to receive a doctor’s recommendation to use and purchase medical marijuana products containing a maximum 10 milligrams of THC.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

SpeedWeed

APRIL 9, 2021

Nearly two-thirds of Texas medical cannabis users said that weed helped them quit using opioids, benzodiazepines, and other prescription medicines, a new survey reports. From August 11th to October 6th, 2020, researchers asked Texas residents who were using cannabis medicinally to answer an anonymous online survey. percent THC content.

Pharmaceutical 52

Pharmaceutical Chronic Pain Programs Patients 52

PrestoDoctor

DECEMBER 12, 2023

The Use of Cannabis Among Seniors More and more seniors are turning to cannabis as an alternative to traditional medications. As the stigma surrounding cannabis use decreases and more research shows the potential benefits, older adults are exploring this natural remedy for various ailments.

Medicine 98

Medicine Chronic Pain Consumption Pharmaceutical 98

SpeedWeed

JUNE 14, 2021

State officials tasked with overseeing Ohio’s medical marijuana program approved last week the addition of three health conditions that qualify a patient to use cannabis medicinally. Spasticity is a medical condition characterized by prolonged muscle contraction and abnormal muscle tightness.

Conditions 40

Conditions Programs Therapy Patients 40

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

United Patients Group

APRIL 18, 2023

Introduction The medical cannabis industry is booming. However, there are still many myths about cannabis that persist despite being debunked by medical professionals and researchers alike. Myth: Cannabis is just a drug. Cannabis is a plant. Myth: Cannabis is a gateway to other drugs. Myth: Cannabis is a cure-all.

Research and Development 108

Research and Development Indica Treatment Conditions 108

United Patients Group

FEBRUARY 7, 2023

Benefits of Cannabis for Inflammation and Pain Introduction Inflammation and pain are two of the most common health issues that many people face. Inflammation can lead to a wide range of diseases and conditions, including heart disease, arthritis and cancer. Cannabis is a plant that has been used for thousands of years.

Cannabinoids 114

Cannabinoids Chronic Pain Terpenes THC 114

CannaTech

JANUARY 16, 2019

Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. It is not a story about profiting off of people.

Access 89

Access Patients Pharmaceutical Education 89

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

DECEMBER 15, 2021

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Pharmaceutical 52

Pharmaceutical Cannabinoids Business Extraction 52

Veriheal

JANUARY 26, 2023

Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. According to recent research, cannabis could offer unique benefits as part of an approach to managing bipolar disorder.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. THC is the primary psychoactive compound in cannabis, responsible for the “high” or euphoric feeling associated with marijuana use.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Cannabis Law Report

JULY 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Current TNF-a inhibitors available today, while effective, come with an array of adverse effects and concerns for patients,” said Adam Kaplin, M.D., About MyMD Pharmaceuticals, Inc. Company plans to initiate Phase II trial with a leading academic institution.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Canna Care Docs

OCTOBER 3, 2023

On top of overwhelming struggles or feelings, patients who have been diagnosed with a terminal illness can face a broad range of both physical and psychological effects. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. InMed has conducted preclinical pharmacology studies that suggest CBN in INM-755 may help relieve hallmark EB symptoms, including inflammation and pain, as well potentially restore the integrity of the skin in a subset of EB Simplex patients.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

JUNE 1, 2022

(TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Europe and Latin America, announces that it has entered into an agreement to acquire Pharmadrug GmbH from its parent PharmaDrug Inc. The transaction is subject to customary closing conditions, including the approval of the TSX Venture Exchange.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. Medical cannabis costs family £4,000 a month to help teenager.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

PrestoDoctor

SEPTEMBER 6, 2023

The legalization of cannabis in some countries and states has brought about significant changes in the healthcare industry. However, with the increasing popularity of cannabis, many people are turning to marijuana as a safer and better alternative for pain management.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Veriheal

OCTOBER 13, 2020

Elevated levels of stress can even land these individuals in more discomfort, with IBD patients risking hospitalization due to inflammation. Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? What is IBS?

Digestion 120

Digestion Treatment Conditions Research and Development 120

FloridaMarijuana.net

JULY 5, 2018

As with all medicinal interventions, strains may affect each person and medical condition differently. Be sure to speak with your medical marijuana physician about their recommendations based on your individual needs and medical conditions. Patients often report feeling relief almost immediately. Super Sour Diesel/Sativa.

Strains 189

Strains Chronic Pain Indica Hybrid 189

Cannabis Law Report

AUGUST 24, 2021

BALTIMORE–(BUSINESS WIRE)– $MYMD — MyMD Pharmaceuticals, Inc. Thus, there is a great need to develop new and effective therapeutics for treating patients. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 98

Pharmaceutical Clinical Trials Chronic Pain CBD 98

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. The development has been welcomed and comes as the nation’s doctors are said to be shifting their cultural stance from viewing ‘cannabis as a dirty word’.

Data 52

Data Patients Clinical Trials Business 52

MMJ Recs

FEBRUARY 3, 2024

In recent years, the landscape of medical marijuana laws has evolved, presenting new opportunities and challenges for patients, healthcare providers, and industry stakeholders. These laws outline the parameters for the cultivation, distribution, and use of medical cannabis within the city.

Legislation 52

Legislation Law Marijuana Dispensary 52

United Patients Group

FEBRUARY 2, 2023

Using Cannabis For Health and Wellness Introduction Cannabis is a plant that has been used for thousands of years to treat many ailments. The first recorded use of cannabis was in 2737 BC, when Emperor Shen Nung documented its value as a medicine. But what exactly is cannabis? This is where cannabis comes in!

Blood Pressure 103

Blood Pressure Sleep Chronic Pain Digestion 103

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. billion 1 by 2025.

Access 105

Access Research and Development Pharmaceutical Therapy 105

SpeedWeed

MARCH 13, 2021

Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success.

Patients 52

Patients Treatment Therapy Sleep 52

FloridaMarijuana.net

JULY 16, 2018

I’ve been self-medicating Marijuana for a little over two years; I didn’t care that it was illegal at the time that I started using cannabis, all I cared about was how I felt afterward. No need to take pills that could do more harm than good; or deal with painful side effects that pharmaceuticals cause. Patient intake form.

Marijuana 189

Marijuana Patients Conditions Treatment 189

Canna Care Docs

SEPTEMBER 18, 2020

You must be a legal resident of Virginia who is able to prove residency in order to apply for a Virginia medical cannabis card. Patients under the age of 18 must also have a parent or guardian registered as a caregiver on their behalf. Patients may purchase a 90 day supply of their medication.

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Cannabis Law Report

JANUARY 18, 2022

Texas Original Compassionate Cultivation assembled a focus group of veterans suffering from PTSD to evaluate symptom response, product preference and effects on supplemental pharmaceutical consumption. The focus group consisted of veterans suffering from PTSD who qualify for medical cannabis under the expanded Compassionate Use Program.

Patients 52

Patients Tincture Pharmaceutical Cultivation 52

MMJ Recs

JANUARY 17, 2024

As the legal landscape surrounding cannabis continues to evolve, an increasing number of arthritis patients are turning to this plant for potential relief. How Medical Marijuana Can Help Arthritis Patients Medical marijuana holds significant promise in providing relief and improving the quality of life for arthritis patients.

Strains 98

Strains Marijuana Indica Microdosing 98